scispace - formally typeset
A

Ana Torres

Researcher at Hospital General Universitario Gregorio Marañón

Publications -  8
Citations -  538

Ana Torres is an academic researcher from Hospital General Universitario Gregorio Marañón. The author has contributed to research in topics: Cilastatin & Cyclosporin a. The author has an hindex of 8, co-authored 8 publications receiving 490 citations.

Papers
More filters
Journal ArticleDOI

The Chemokine Receptor CCR7 Activates in Dendritic Cells Two Signaling Modules That Independently Regulate Chemotaxis and Migratory Speed

TL;DR: CCR7 activates two independent signaling modules, one involving Gi and a hierarchy of MAPK family members and another involving Rho/Pyk2/cofilin, which control, respectively, chemotaxis and the migratory speed of DCs.
Journal ArticleDOI

Potentiation by Nitric Oxide of Cyclosporin A and FK506-Induced Apoptosis in Renal Proximal Tubule Cells

TL;DR: The conclusion is that the cooperation between NO and Immunosuppressors that induce apoptosis in PTEC might contribute to the renal toxicity observed in the course of immunosuppressive therapy.
Journal ArticleDOI

Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage

TL;DR: It is suggested that the affinity of cilastatin for renal dipeptidase makes this effect specific for proximal tubular cells and may be related to a reduction in intracellular drug accumulation.
Journal ArticleDOI

Abnormal Transition Pore Kinetics and Cytochrome C Release in Muscle Mitochondria of Patients with Chronic Obstructive Pulmonary Disease

TL;DR: MPTP kinetics and cyto-c release are abnormal in skeletal and respiratory muscles of patients with moderate COPD, suggesting a systemic mechanism(s) occurring early during the course of the disease.
Journal ArticleDOI

Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells

TL;DR: Preventing CyA-induced reduction of cell membrane fluidity and inhibition of CyA transport are features of cilastatin's direct effects on PTECs, and unaltered distribution of MBCRs in the presence of cILastatin suggests that cilastsatin binding to raft-bound dipeptidases, rather than MBCR modifications, causes interference withCyA transport.